Normal Basal Epithelial Cells Stimulate the Migration and Invasion of Prostate Cancer Cell RM-1 by TGF-β1/STAT3 Axis in vitro

References

• Chen W, Ten DP. Immunoregulation by members of the TGFbeta superfamily. Nat Rev Immunol. 2016;16(12):723–740. doi:10.1038/nri.2016.11227885276
   PubMed Web of Science ®Google Scholar
• Massague J. TGFbeta in cancer. Cell. 2008;134(2):215–230. doi:10.1016/j.cell.2008.07.00118662538
   PubMed Web of Science ®Google Scholar
• Khan MI, Hamid A, Adhami VM, Lall RK, Mukhtar H. Role of epithelial mesenchymal transition in prostate tumorigenesis. Curr Pharm Des. 2015;21(10):1240–1248. doi:10.2174/138161282166614121112032625506896
   PubMed Web of Science ®Google Scholar
• Salm SN, Koikawa Y, Ogilvie V, et al. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines. J Cell Physiol. 2000;184(1):70–79. doi:10.1002/(SICI)1097-4652(200007)184:1<70::AID-JCP7>3.0.CO;2-U10825235
   PubMed Web of Science ®Google Scholar
• Lee H, Jeong AJ, Ye SK. Highlighted STAT3 as a potential drug target for cancer therapy. BMB Rep. 2019;52(7):415–423. doi:10.5483/BMBRep.2019.52.7.15231186087
   PubMed Web of Science ®Google Scholar
• Qin HR, Kim HJ, Kim JY, et al. Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation. Cancer Res. 2008;68(19):7736–7741. doi:10.1158/0008-5472.CAN-08-112518829527
   PubMed Web of Science ®Google Scholar
• Johnson DE, O’Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234–248. doi:10.1038/nrclinonc.2018.829405201
   PubMed Web of Science ®Google Scholar
• You L, Wang Z, Li H, et al. The role of STAT3 in autophagy. Autophagy. 2015;11(5):729–739. doi:10.1080/15548627.2015.101719225951043
   PubMed Web of Science ®Google Scholar
• Galoczova M, Coates P, Vojtesek B. STAT3, stem cells, cancer stem cells and p63. Cell Mol Biol Lett. 2018;23(1):12. doi:10.1186/s11658-018-0078-029588647
   PubMed Web of Science ®Google Scholar
• Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014;14(11):736–746. doi:10.1038/nrc381825342631
   PubMed Web of Science ®Google Scholar
• Wang B, Liu T, Wu JC, et al. STAT3 aggravates TGF-beta1-induced hepatic epithelial-to-mesenchymal transition and migration. Biomed Pharmacother. 2018;98:214–221. doi:10.1016/j.biopha.2017.12.03529268242
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu C, Zhang C, et al. TGF-beta-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions. Cancer Lett. 2018;436:52–62. doi:10.1016/j.canlet.2018.08.00930118844
   PubMed Web of Science ®Google Scholar
• Cho KH, Jeong KJ, Shin SC, Kang J, Park CG, Lee HY. STAT3 mediates TGF-beta1-induced TWIST1 expression and prostate cancer invasion. Cancer Lett. 2013;336(1):167–173. doi:10.1016/j.canlet.2013.04.02423623921
   PubMed Web of Science ®Google Scholar
• Wang H, Tang F, Bian E, et al. IFITM3/STAT3 axis promotes glioma cells invasion and is modulated by TGF-beta. Mol Biol Rep. 2020;47(1):433–441. doi:10.1007/s11033-019-05146-231637620
   PubMed Web of Science ®Google Scholar
• Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev. 2010;24(18):1967–2000. doi:10.1101/gad.196581020844012
   PubMed Web of Science ®Google Scholar
• El-Alfy M, Pelletier G, Hermo LS, Labrie F. Unique features of the basal cells of human prostate epithelium. Microsc Res Tech. 2000;51(5):436–446. doi:10.1002/1097-0029(20001201)51:5<436::AID-JEMT6>3.0.CO;2-T11074614
   PubMed Web of Science ®Google Scholar
• Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Identification of a cell of origin for human prostate cancer. Science. 2010;329(5991):568–571. doi:10.1126/science.118999220671189
   PubMed Web of Science ®Google Scholar
• Stoyanova T, Cooper AR, Drake JM, et al. Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells. Proc Natl Acad Sci U S A. 2013;110(50):20111–20116. doi:10.1073/pnas.132056511024282295
   PubMed Web of Science ®Google Scholar
• Magi-Galluzzi C. Prostate cancer: diagnostic criteria and role of immunohistochemistry. Mod Pathol. 2018;31(S1):S12–21. doi:10.1038/modpathol.2017.13929297490
   PubMed Web of Science ®Google Scholar
• Man YG, Gardner WA. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion. Med Hypotheses. 2008;70(2):387–408. doi:10.1016/j.mehy.2007.05.01517658698
   PubMed Web of Science ®Google Scholar
• Diaz JI, Cazares LH, Corica A, John SO. Selective capture of prostatic basal cells and secretory epithelial cells for proteomic and genomic analysis. Urol Oncol. 2004;22(4):329–336. doi:10.1016/j.urolonc.2004.04.01015283892
   PubMed Web of Science ®Google Scholar
• Miniati DN, Chang Y, Shu WP, Peehl DM, Liu BC. Role of prostatic basal cells in the regulation and suppression of human prostate cancer cells. Cancer Lett. 1996;104(2):137–144. doi:10.1016/0304-3835(96)04243-78665481
   PubMed Web of Science ®Google Scholar
• Yu HM, Frank DE, Zhang J, You X, Carter WG, Knudsen BS. Basal prostate epithelial cells stimulate the migration of prostate cancer cells. Mol Carcinog. 2004;41(2):85–97. doi:10.1002/mc.2004115378647
   PubMed Web of Science ®Google Scholar
• Guo C, Huang T, Wang QH, et al. Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells. Cancer Cell Int. 2019;19:170. doi:10.1186/s12935-019-0889-831297034
   PubMed Web of Science ®Google Scholar
• Sur S, Steele R, Shi X, Ray RB. miRNA-29b inhibits prostate tumor growth and induces apoptosis by increasing bim expression. Cells-Basel. 2019;8(11).
   Google Scholar
• Xin L. Cells of origin for cancer: an updated view from prostate cancer. Oncogene. 2013;32(32):3655–3663. doi:10.1038/onc.2012.54123178496
   PubMed Web of Science ®Google Scholar
• Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci U S A. 2010;107(6):2610–2615. doi:10.1073/pnas.091387310720133806
   PubMed Web of Science ®Google Scholar
• Lee SH, Shen MM. Cell types of origin for prostate cancer. Curr Opin Cell Biol. 2015;37:35–41. doi:10.1016/j.ceb.2015.10.00226506127
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhou X, Gao H, Ji SJ, Wang C. The expression of epidermal growth factor and transforming growth factor-beta1 in the stenotic tissue of congenital pelvi-ureteric junction obstruction in children. J Pediatr Surg. 2003;38(11):1656–1660. doi:10.1016/S0022-3468(03)00577-314614718
   PubMed Web of Science ®Google Scholar
• Sun DY, Wu JQ, He ZH, He MF, Sun HB. Cancer-associated fibroblast regulate proliferation and migration of prostate cancer cells through TGF-beta signaling pathway. Life Sci. 2019;235(2019):116791. doi:10.1016/j.lfs.2019.11679131465732
   PubMed Web of Science ®Google Scholar
• Zhang D, Qiu X, Li J, Zheng S, Li L, Zhao H. TGF-beta secreted by tumor-associated macrophages promotes proliferation and invasion of colorectal cancer via miR-34a-VEGF axis. Cell Cycle. 2018;17(24):2766–2778. doi:10.1080/15384101.2018.155606430523755
   PubMed Web of Science ®Google Scholar
• Costanza B, Umelo IA, Bellier J, Castronovo V, Turtoi A. Stromal modulators of TGF-beta in cancer. J Clin Med. 2017;6(1):7. doi:10.3390/jcm6010007
   PubMed Web of Science ®Google Scholar
• Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal. 2014;7(344):e8. doi:10.1126/scisignal.2005189
   Web of Science ®Google Scholar
• Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009;28(1–2):15–33. doi:10.1007/s10555-008-9169-019169796
   PubMed Web of Science ®Google Scholar
• Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166(1):21–45.27368099
   PubMed Web of Science ®Google Scholar
• Giannelli G, Koudelkova P, Dituri F, Mikulits W. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016;65(4):798–808. doi:10.1016/j.jhep.2016.05.00727212245
   PubMed Web of Science ®Google Scholar
• Odero-Marah V, Hawsawi O, Henderson V, Sweeney J. Epithelial-mesenchymal transition (EMT) and prostate cancer. Adv Exp Med Biol. 2018;1095:101–110.30229551
   PubMed Web of Science ®Google Scholar
• Gheldof A, Berx G. Cadherins and epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci. 2013;116:317–336.23481201
   PubMed Web of Science ®Google Scholar
• Ogata H, Chinen T, Yoshida T, et al. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene. 2006;25(17):2520–2530. doi:10.1038/sj.onc.120928116474852
   PubMed Web of Science ®Google Scholar
• Liu Q, Tong D, Liu G, et al. Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-beta1/STAT3 axis-regulated EMT. Cell Death Dis. 2017;8(8):e3007. doi:10.1038/cddis.2017.41728837141
   PubMed Web of Science ®Google Scholar
• Namekawa T, Ikeda K, Horie-Inoue K, Inoue S. Application of Prostate Cancer Models for Preclinical Study: advantages and limitations of cell lines, patient-derived xenografts, and three-dimensional culture of patient-derived cells. Cells. 2019;8(1).
   PubMed Web of Science ®Google Scholar
• Grant JF, Iwasawa T, Sinn HW, et al. Induction of protective immunity to RM-1 prostate cancer cells with ALVAC-IL-2/IL-12/TNF-alpha combination therapy. Int J Cancer. 2006;119(11):2632–2641. doi:10.1002/ijc.2222016991124
   PubMed Web of Science ®Google Scholar
• Bonkhoff H, Stein U, Remberger K. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate. 1994;24(3):114–118. doi:10.1002/pros.29902403037509483
   PubMed Web of Science ®Google Scholar
• Bostwick DG, Pacelli A, Lopez-Beltran A. Ultrastructure of prostatic intraepithelial neoplasia. Prostate. 1997;33(1):32–37. doi:10.1002/(SICI)1097-0045(19970915)33:1<32::AID-PROS6>3.0.CO;2-B9294624
   PubMed Web of Science ®Google Scholar